Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2015

Open Access 01-12-2015 | Primary research

Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues

Authors: Fanghui Ren, Hua Ding, Suning Huang, Hanlin Wang, Mei Wu, Dianzhong Luo, Yiwu Dang, Lihua Yang, Gang Chen

Published in: Cancer Cell International | Issue 1/2015

Login to get access

Abstract

Background

Aberrant expression of miR-193a-3p and astrocyte elevated gene-1 (AEG-1) have been revealed to be related to the tumorigenesis of various cancers, including non-small cell lung cancer (NSCLC). However, the significance of miR-193a-3p and its correlation with AEG-1 in NSCLC has not been explored. The purpose of this study was to evaluate the association between miR-193a-3p and AEG-1 and their relationship with the clinicopathological features in NSCLC patients.

Methods

Via online in silico prediction, complementary sequences were found between miR-193a-3p and the 3′-untranslated region of AEG-1. Three independent cohorts were applied in the current study. Firstly, miR-193a-3p level was detected in 125 cases of NSCLC with quantitative real-time PCR (qRT-PCR). Secondly, AEG-1 protein level was evaluated in 339 cases of lung cancers with immunohistochemistry. Finally, the relationship between miR-193a-3p and AEG-1 protein expression was verified in another group with 65 cases of NSCLC.

Results

The results showed that miR-193a-3p level was decreased in NSCLC tissues and significantly negatively related to tumor size (r = −0.277, P = 0.002), clinical TNM stage (r = −0.226, P = 0.011), lymph node metastasis (r = −0.186, P = 0.038), epidermal growth factor receptor (EGFR) protein level (r = −0.272, P = 0.041). On the contrary, AEG-1 protein expression was up-regulated in NSCLC and positively relative to tumor size (r = 0.240, P < 0.001), TNM stages (r = 0.164, P = 0.002) and lymph node metastasis (r = 0.232, P < 0.001) in NSCLC patients. In addition, miR-193a-3p was found to be inversely associated with AEG-1 protein expression in the third cohort (r = −0.564, P < 0.001).

Conclusion

In conclusion, miR-193a-3p and AEG-1 might be responsible for the carcinogenesis and aggressiveness of NSCLC. AEG-1 has the potential to be one of the targeted genes of miR-193a-3p. However, future in vitro and in vivo experiments are needed to verify this hypothesis.
Literature
1.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108PubMedCrossRef
2.
Ramalingam SS, Owonikoko TK, Khuri FR (2011) Lung cancer: new biological insights and recent therapeutic advances. CA Cancer J Clin 61:91–112PubMedCrossRef
3.
Huang S, He R, Rong M, Dang Y, Chen G (2014) Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells. Biomed Res Int 2014:384121PubMedCentralPubMed
4.
Li J, Tan Q, Yan M, Liu L, Lin H, Zhao F et al (2014) miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25. Mol Cancer 13:166PubMedCentralPubMedCrossRef
5.
Wang H, Zhu Y, Zhao M, Wu C, Zhang P, Tang L et al (2013) miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin beta1 and matrix metalloproteinase2 (MMP2). PLoS One 8:e70192PubMedCentralPubMedCrossRef
6.
Salim H, Arvanitis A, de Petris L, Kanter L, Haag P, Zovko A et al (2013) miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression. Genes Chromosom Cancer 52:895–911PubMedCrossRef
7.
Xie C, Han Y, Liu Y, Han L, Liu J (2014) miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer. Int J Clin Exp Pathol 7:7518–7526PubMedCentralPubMed
8.
Lv J, Xu L, Xu Y, Qiu M, Yang X, Wang J et al (2014) Expression of MiRNA-221 in non-small cell lung cancer tissues and correlation with prognosis. Zhongguo Fei Ai Za Zhi 17:221–225PubMed
9.
Deng H, Lv L, Li Y, Zhang C, Meng F, Pu Y et al (2015) The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer. Biochim Biophys Acta 1852:520–528PubMedCrossRef
10.
Lv L, Li Y, Deng H, Zhang C, Pu Y, Qian L et al (2015) MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene. Cancer Lett 357:105–113PubMedCrossRef
11.
Deng H, Lv L, Li Y, Zhang C, Meng F, Pu Y et al (2014) miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the Oxidative Stress pathway. Mol Cancer. 13:234PubMedCentralPubMedCrossRef
12.
Iliopoulos D, Rotem A, Struhl K (2011) Inhibition of miR-193a expression by Max and RXRalpha activates K-Ras and PLAU to mediate distinct aspects of cellular transformation. Cancer Res 71:5144–5153PubMedCentralPubMedCrossRef
13.
Nakano H, Yamada Y, Miyazawa T, Yoshida T (2013) Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. Int J Oncol 42:1875–1882PubMedCentralPubMed
14.
Heller G, Weinzierl M, Noll C, Babinsky V, Ziegler B, Altenberger C et al (2012) Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. Clin Cancer Res 18:1619–1629PubMedCrossRef
15.
Liang H, Liu M, Yan X, Zhou Y, Wang W, Wang X et al (2015) miR-193a-3p Functions as a Tumor Suppressor in Lung Cancer by Down-regulating ERBB4. J Biol Chem 290:926–940PubMedCrossRef
16.
Wang J, Yang B, Han L, Li X, Tao H, Zhang S et al (2013) Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines. Cell Physiol Biochem 32:1707–1719PubMedCrossRef
17.
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F et al (2015) MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway. Oncogene 34:413–423PubMedCrossRef
18.
19.
Ke ZF, Mao X, Zeng C, He S, Li S, Wang LT (2013) AEG-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosis. Med Oncol 30:383PubMedCrossRef
20.
Liu K, Guo L, Guo Y, Zhou B, Li T, Yang H et al (2015) AEG-1 3′-untranslated region functions as a ceRNA in inducing epithelial-mesenchymal transition of human non-small cell lung cancer by regulating miR-30a activity. Eur J Cell Biol 94:22–31PubMedCrossRef
21.
Liu K, Guo L, Miao L, Bao W, Yang J, Li X et al (2013) Ursolic acid inhibits epithelial-mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer A549 cells. Anticancer Drugs 24:494–503PubMedCrossRef
22.
Song L, Li W, Zhang H, Liao W, Dai T, Yu C et al (2009) Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol. 219:317–326PubMedCrossRef
23.
Sun S, Ke Z, Wang F, Li S, Chen W, Han A et al (2012) Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression. Hum Pathol 43:1051–1060PubMedCrossRef
24.
Wang M, Wang J, Deng J, Li X, Long W, Chang Y (2015) MiR-145 acts as a metastasis suppressor by targeting metadherin in lung cancer. Med Oncol 32:344PubMedCrossRef
25.
26.
Suh SS, Yoo JY, Cui R, Kaur B, Huebner K, Lee TK et al (2014) FHIT suppresses epithelial-mesenchymal transition (EMT) and metastasis in lung cancer through modulation of microRNAs. PLoS Genet 10:e1004652PubMedCentralPubMedCrossRef
27.
Zhang J, Gold KA, Lin HY, Swisher SG, Xing Y, Lee JJ et al (2015) Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry. J Thorac Oncol 10:682–690PubMedCrossRef
28.
Yao Y, Gu X, Liu H, Wu G, Yuan D, Yang X et al (2014) Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer. Br J Cancer 111:355–364PubMedCentralPubMedCrossRef
29.
Chen G, Kronenberger P, Teugels E, Umelo IA, De Greve J (2012) Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. BMC Med 10:28PubMedCentralPubMedCrossRef
30.
Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P et al (2013) miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One 8:e60317PubMedCentralPubMedCrossRef
31.
Rong M, He R, Dang Y, Chen G (2014) Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues. Ups J Med Sci 119:19–24PubMedCentralPubMedCrossRef
32.
Zhang X, Li P, Rong M, He R, Hou X, Xie Y et al (2015) MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients. Tohoku J Exp Med 235:161–169PubMedCrossRef
Metadata
Title
Expression and clinicopathological significance of miR-193a-3p and its potential target astrocyte elevated gene-1 in non-small lung cancer tissues
Authors
Fanghui Ren
Hua Ding
Suning Huang
Hanlin Wang
Mei Wu
Dianzhong Luo
Yiwu Dang
Lihua Yang
Gang Chen
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2015
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-015-0227-8

Other articles of this Issue 1/2015

Cancer Cell International 1/2015 Go to the issue

Primary research

Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts

Primary research

Overexpression of MALT1-A20-NF-κB in adult B-cell acute lymphoblastic leukemia

Primary research

Differential effects of HIF-α isoforms on apoptosis in renal carcinoma cell lines

Primary research

Transient knockdown-mediated deficiency in plectin alters hepatocellular motility in association with activated FAK and Rac1-GTPase

Primary research

RETRACTED ARTICLE: Hypericin-mediated photodynamic therapy induces apoptosis of myoloma SP2/0 cells depended on caspase activity in vitro

Primary research

Interferon gamma polymorphisms and hepatitis B virus-related liver cirrhosis risk in a Chinese population
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits